Showing results (191-200 of 347) with videos related to
Sort By:
Pageof 35
Frontiers in Public Health|January 10, 2022
Risk Factors for Childhood Leukemia: Radiation and BeyondJanine-Alison Schmidt, Sabine Hornhardt, Friederike Erdmann, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 27, 2011
Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefactsVerena Wilhelmi, Ute Fischer, Damiën van Berlo, et al.Chemmedchem|February 25, 2021
Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia ActivityMarc Pflieger, Melf Sönnichsen, Nadine Horstick-Muche, et al.Angewandte Chemie (International Ed. in English)|August 12, 2020
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)Laura Sinatra, Jan J Bandolik, Martin Roatsch, et al.Journal of Clinical Immunology|July 31, 2016
Fatal Lymphoproliferative Disease in Two Siblings Lacking Functional FAAP24Svenja Daschkey, Kirsten Bienemann, Volker Schuster, et al.European Journal of Medicinal Chemistry|May 7, 2024
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Julian Schliehe-Diecks, Lukas von Bredow, et al.Human Mutation|July 29, 2014
A new workflow for whole-genome sequencing of single human cellsVera Binder, Christoph Bartenhagen, Vera Okpanyi, et al.Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget DrugsLukas von Bredow, Thomas Martin Schäfer, Julian Hogenkamp, et al.Clinical Immunology (Orlando, Fla.)|December 10, 2008
Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndromeStefan Schönberger, Hagen Ott, Sonja Gudowius, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemiaAndrea Meinhardt, Birgit Burkhardt, Martin Zimmermann, et al.Pageof 35